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INCREASED cAMP mediates relaxation in airway smooth muscle by the activation of protein kinase A (PKA), which, in turn, activates a cascade of poorly understood pathways facilitating relaxation. These cellular targets of PKA result in decreased calcium levels and the phosphorylation of proteins favoring relaxation (8) .
cAMP is synthesized by a nine-member family of adenylyl cyclase enzymes that are divided into subfamilies based on their regulatory patterns in response to products of other second messenger pathways (10) . Group 1 includes isoforms I, III, and VIII, which are stimulated by calcium/calmodulin (3, 5, 29) . Group 2 includes isoforms II, IV, and VII, which are regulated by G protein ␤␥-subunits (4, 7, 11) . Group 3 includes isoforms V and VI, which are inhibited by micromolar concentrations of calcium (16, 34) , are regulated by PKA (13) and protein kinase C (PKC; see Refs. 14, 17, 35) , and are inhibited by ␤␥-subunits (1) . Group 4 includes isoform IX, which is insensitive to calcium (23) , ␤␥-subunits, or forskolin (32) . Individual cell types can simultaneously express multiple isoforms of adenylyl cyclases (6, 19) . Thus this allows for the complex regulation of the net cellular synthesis of cAMP by second messenger products of multiple other signaling pathways. It is unknown in airway smooth muscle which isoforms of adenylyl cyclase are predominantly expressed, how isoform-specific expression might be chronically regulated, or how products of other second messenger pathways ultimately influence the net synthesis of cAMP.
Adenylyl cyclase proteins are present in low levels in most cells (0.01-0.001% of membrane protein), making their immunodetection difficult (30) . Thus most studies have relied on mRNA expression to determine organor cell-specific expression of different isoforms. Early mRNA studies relied on Northern blot analysis, which initially suggested that some isoforms had very limited expression (e.g., type III in neuroepithelium), but further studies using more sensitive detection techniques of ribonuclease protection and RT-PCR revealed a more diverse expression of most isoforms (28) . Yet most of these mRNA surveys to date have relied upon tissuewide distribution, with less information available regarding cell-specific expression within an organ (10, 24, 28) . This is especially true in the lung where most adenylyl cyclase mRNA expression studies have evaluated mRNA in the whole lung (10, 28) , which is a heterogeneous mixture of cell types of the respiratory, vascular, hematopoietic, and peripheral nervous systems. Little is known regarding the cell-specific expression of adenylyl cyclase isoforms in airway smooth muscle cells where the cellular levels of cAMP are a key determinant of airway smooth muscle tone. Studies of adenylyl cyclase mRNA expression in specific human cell types have been hampered to date by incomplete human cDNA sequence information for all nine human adenylyl cyclase isoforms. The current study was designed to first identify nondegenerate primers that would selectively amplify all nine known isoforms of human adenylyl cyclases. Subsequently, we sought to determine which mRNAs encoding isoforms of adenylyl cyclases are expressed in human airway smooth muscle cells using RT-PCR. Additionally, preactivation of PKA and PKC before adenylyl cyclase functional assays and immunoblot analyses offered insights into the likely functionally predominant isoforms of adenylyl cyclase proteins in human airway smooth muscle.
METHODS

RNA Extraction
Total RNA from dissected human airway smooth muscle and total RNA from primary cultures of airway smooth muscle were used in these studies. Positive control total RNA from human whole brain, human whole trachea, and rat whole brain were commercially purchased (Clontech, Palo Alto, CA). These human brain and trachea RNAs were extracted from a pool of 70 male/female and 2 male tissue specimens, respectively. The whole human trachea RNA was extracted from the entire trachea, which included many cell types. Upon arrival, the RNA in ethanol was spun down at 15,000 g for 15 min to discard the ethanol supernatant, and the RNA pellet was washed with 70% ethanol and centrifuged again. The final pellet was dissolved in RNase-free water at 1 g/l and stored in aliquots at Ϫ80°C.
Human airway smooth muscle was dissected from a region of trachea just above the carina within 12 h of death. Tracheae were submerged in cell culture medium during dissection under a dissecting microscope. The submucosa was removed, and the tracheal smooth muscle was carefully dissected away from the underlying connective tissue. Dissected tracheal muscle was rapidly frozen and stored at Ϫ80°C until isolation of total RNA. Detailed characterizations of the primary cultures of human airway smooth muscle cells have been reported previously (9) . Total RNA from dissected airway smooth muscle and from primary cultures of human airway smooth muscle cells was extracted by a modified Chomczynski and Sacchi method using TRIzol reagent (Life Technologies, Gaithersburg, MD). For dissected airway smooth muscle, 200-400 mg of muscle were homogenized in 3-6 ml of TRIzol reagent. Samples were homogenized at top speed using an Ultra-Turrex homogenizer (Tekmar-Dohrmann, Cincinnati, OH) equipped with a T-25 probe. Five cycles of homogenization occurred for 5-10 s each, with cooling of the samples on ice between cycles. The homogenates from dissected airway smooth muscle were subjected to centrifugation at 12,000 g for 10 min to remove nonsoluble cellular debris before the supernatant was transferred to a clean tube with the addition of a 1:5 volume of chloroform. For cultured cells, 5 ml of TRIzol reagent were added directly to a 75-cm 2 flask, and the cells were transferred to tubes. After incubation at room temperature for 10 min, 1:5 volume of chloroform was added. After vigorous shaking and room temperature incubation for 3 min, both the homogenate and cultured cell samples were centrifuged at 12,000 g for 15 min at 4°C to separate the phases. The upper aqueous phase containing the RNA was transferred to a clean tube to which an equal volume of isopropyl alcohol was added. Centrifugation at 12,000 g for 10 min at 4°C yielded an RNA pellet that was washed in 75% ethanol followed by centrifugation at 7,500 g for 5 min at 4°C. The final resulting RNA pellet was air-dried and redissolved in 100 l of RNase-free water.
Adenylyl Cyclase Isoform-Specific Primer Design
Primers were designed using Oligo 5.0 software and were based on published GenBank sequences for human adenylyl cyclase isoforms (Table 1) , except for isoform IV for which no human sequence was available. Isoform IV primers were designed based on a partial human GenBank sequence (AF088070) that has high homology to rat adenylyl cyclase type IV (M80633). Primer pairs were chosen to yield expected PCR products of 150-600 bp. All primers were purchased from Genosys (The Woodlands, TX) or Life Technologies with standard purification. All primers were dissolved in DNaseand RNase-free water at a stock concentration of 100 M, further diluted to a working concentration of 10 M, and stored at Ϫ20°C. AC1 5Ј  L05500  5Ј-CAT GAC CTG CGA GGA CGA T-3Ј  19  AC1 3Ј  5Ј-ACA GGA GAC TGC GAA TCT GAA-3Ј  21  AC2 5Ј  X74210  5Ј-GGG GCT GCG TTT CTC T-3Ј  16  AC2 3Ј  5Ј-CAG GAA CAC GGA ACA GGA TA-3Ј  20  AC3 5  NM_004036  5Ј-CAC GGG ACC CAG CAA T-3Ј  16  AC3 3Ј  5Ј-GCT CTA AGG CCA CCA TAG GTA-3Ј  21  AC4 5Ј  AF088070  5Ј-TGA ACC ATG GAC CCG TAG-3Ј  18  AC4 3Ј  5Ј-GCG AGT GCA ATC TCA GC-3Ј  17  AC5 5Ј  U65473  5Ј-ACC AAG GCT ACA CTC AAC TAC-3Ј  21  AC5 3Ј  5Ј-GGT TCA TCT TGG CGA TCA-3Ј  18  AC6 5Ј  AB007882  5Ј-GGC ATT GAT GAT TCC AGC AAA GAC-3Ј  24  AC6 3Ј  5Ј-TGC AGG GCC TTA GGG AAC AGA-3Ј  21  AC7 5  NM_001114  5Ј-TTA GCA CAT GAT GAA AAC AGA CTT-3Ј  24  AC7 3Ј  5Ј-CAC TGG AGG GAA GAG ATT TAT G-3Ј  22  AC8 5Ј  NM_001115  5Ј-CGG GAT TTG GAA CGC CTC TA-3Ј  18  AC8 3Ј 5Ј-CCG GTC TGA CAG GTA ACT GAT AA-3Ј 23 AC9 5Ј NM_001116 5Ј-CAC CGC AAA ATA CTT AGA TGA CG-3Ј 23 AC9 3Ј
5Ј-CCT TCT CCT GCA AGA TCT CAC AC-3Ј 23
RT-PCR
Total RNA from whole human brain was used as a positive control to ensure that RT-PCR yielded an appropriately sized PCR product for each human-specific adenylyl cyclase primer set. Rat whole brain total RNA was used as a negative control, since all human primer sets used except isoforms V and VIII have low homology to the respective rat adenylyl cyclase sequences. Additional controls included parallel tubes containing all reaction components except reverse transcriptase to ensure that PCR products did not arise from contaminating cDNA or genomic DNA. Parallel tubes that contained all reaction components except RNA were also included to ensure a lack of reagent contamination. RT-PCR experiments were performed with RNA isolated from at least three independent samples of dissected human tracheal smooth muscle and three independent samples of human primary cultured cells for each adenylyl cyclase primer set.
DNase pretreatment, RT, and PCR were all performed on an RNA sample in a single tube. Unless indicated otherwise, 1 g of total RNA from commercial sources (positive controls) or from dissected or primary cultured human airway smooth muscle was used in each tube. Initially, all RNA samples were treated with RNase-free DNase (Ambion, Austin, TX) for 1 h at 37°C to degrade contaminating DNA. Total RNA was incubated with RNase-free DNase (0.5 l; 2 U/l) in the same tube, and buffer was used for subsequent RT-PCR [1ϫ concentration of proprietary reaction buffer (Access RT-PCR kit; Promega, Madison, WI), 1 mM MgSO 4, 0.2 mM dNTPs, and 0.8 M each primer] in a volume of 24 l. Samples were then heated to 70°C for 5 min to inactivate the DNase enzyme, and, after cooling on ice, 0.5-l aliquots each of AMV reverse transcriptase (5 U/l) and Tfl DNA polymerase (5 U/l) were added to each tube. First-strand cDNA synthesis was performed at 48°C for 45 min, at which time the reaction was heated to 94°C for 5 min to inactivate the reverse transcriptase.
PCR was immediately performed for 40 cycles in a thermal cycler (PT-200 MJ Research, Waltham, MA) equipped with a heated lid. Denaturation and extension temperatures/times of 95°C/30 s and 68°C/1 min were used, respectively. Oneminute annealing times were used for all reactions at 52°C for isoforms I, II, and VIII, at 50°C for isoform III, at 55°C for isoforms IV, V, and VII, and at 58°C for isoforms VI and IX.
Nondenaturing Polyacrylamide Gel, Restriction
Endonucleases Analysis, and DNA Sequencing PCR products were separated on nondenaturing 5-8% polyacrylamide gels (mono/bis ϭ 39:1) using a 100-bp DNA ladder (Promega) as a DNA size standard and as an estimate of DNA concentrations. Gels were stained with ethidium bromide and visualized using a Fluor-S MultiImager (BioRad, Hercules, CA). PCR products were isolated from gels by excising a gel slice and incubating overnight at 37°C in a minimal volume of water. Eluted DNA was quantified by ultraviolet (UV) spectrophotometry. Two approaches were used to confirm the identity of RT-PCR products. Restriction enzyme digests were performed using enzymes predicted to cut within the specifically amplified adenylyl cyclase sequence. Digestion maps were generated using WebCutter software. All restriction digests were performed for 2 h at 37°C in a final volume of 10 l. Digested and undigested RT-PCR products were analyzed on 5-8% polyacrylamide gels. Second, specifically identified RT-PCR products were directly sequenced using automated sequence analysis at the DNA Core Facility of the Columbia University Cancer Center. Sequence analysis was visualized using EditView 1.0.1, and homologies to expected adenylyl cyclase sequences were confirmed using National Center for Biotechnology Information Blast Search.
Preparation of Sense RNA for Adenylyl Cyclase Types II and VIII
For the two isoforms of adenylyl cyclase not identified in freshly dissected or cultured airway smooth muscle (isoforms II and VIII), we generated sense RNA templates of known quantity. By adding these templates of known quantities back to our RNA preparations, we could evaluate the following two issues: 1) we could be sure that the lack of RT-PCR products obtained with smooth muscle RNA was not the result of the presence of a nonspecific inhibitor of the RTPCRs in these samples, and 2) by using serial dilutions of the control sense RNA template, we could determine the sensitivity of our RT-PCR and therefore know the lower limit of sensitivity for the detection of isoforms II and VIII in our samples.
RT-PCR products for isoforms II and VIII were obtained from RT-PCRs from RNA of total human brain. These PCR products were gel purified, excised, and eluted in water overnight. Eluted cDNA then served as the template for a second round of PCR using Taq polymerase to obtain PCR products with "T-A" overhangs at each end. These PCR products were subcloned into pCR II-TOPO (Invitrogen, Carlsbad, CA) in which Sp6 and T7 RNA polymerase binding sites flank the insertion site. Plasmids were transformed into competent Escherichia coli, and isolated colonies were chosen. Aliquots of colonies were lysed at 94°C for 5 min in PCR buffer solution containing primers for either adenylyl cyclase II or VIII. Thirty cycles of PCR were initiated with the addition of Tfl DNA polymerase. Aliquots of PCRs were subjected to gel electrophoresis, and reactions containing products of appropriate size were subjected to another round of PCR using M13 forward and reverse primers, which yielded a linear template with Sp6 and T7 polymerase sites at each end of the adenylyl cyclase DNA fragment. Orientation was confirmed by restriction enzyme digests. The products of these PCRs were gel purified and used as the DNA template for the synthesis of sense RNA using an in vitro transcription kit (Ambion).
These newly synthesized sense RNA transcripts for adenylyl cyclases II and VIII were quantitated by UV spectrophotometry and serially diluted before storage at Ϫ80°C. These RNA sense transcripts for adenylyl cyclase II or VIII were added to RNA samples of airway smooth muscle at 10-fold decreasing quantities (from 1 pg to 0.1 fg/reaction) to confirm our ability to amplify this RNA control template in the presence of airway smooth muscle total RNA and also to determine the lowest quantity of RNA template that could be detected.
Additional Attempts to Amplify mRNA Encoding Adenylyl Cyclase II
Because of a recent report that adenylyl cyclase II mRNA was amplified by RT-PCR in human cultured airway smooth muscle cells (2), we performed additional experiments with the specific primers described in this previous report. The sense primer was 5Ј-acgtctcgagcgactacagccaggtcttat-3Ј, and the antisense primer was 5Ј-gttgctcgagatatcatattgtggcttctgagc-3Ј. RT-PCR conditions were identical to those described above with an annealing temperature of 55°C. Parallel tubes were assembled containing 1 g of total RNA extracted from whole human brain, human airway smooth muscle, and primary cultures of airway smooth muscle cells.
Adenylyl Cyclase Assays and Pretreatments
Adenylyl cyclase activity was measured as previously described (12) . PKC and PKA are known to selectively regulate certain isoforms of adenylyl cyclase. To determine if these isoforms are functionally important in airway smooth muscle, PKC or PKA were preactivated, using phorbol ester or the Sp-diastereomer of adenosine 3Ј,5Ј-cyclic monophosphothioate (Sp-cAMPS), respectively, before forskolin-stimulated adenylyl cyclase activity was measured. Briefly, confluent cells in 24-well plates were washed one time with warm PBS (37°C) and resuspended in 100 l of warm PBS. Cells were pretreated for 15 min with nothing, 1 M phorbol 12-myristate 13-acetate, or 100 M Sp-cAMPS. Fifty microliters of 3ϫ adenylyl cyclase buffer (12) were added directly to the wells, and plates were incubated at 37°C for 10 min. The reactions were terminated by addition of 100 l of stop buffer, and synthesized [ 32 P]cAMP was quantitated as described previously (12) .
Immunoblot Analysis
Membranes were prepared from confluent cultured human airway smooth muscle cells grown in T-75 flasks and whole rat brain. Whole rat brain was used as a positive control for immunoblotting, since all known isoforms of adenylyl cyclase are expressed in brain. Cultured cells were washed two times with 10 ml of wash buffer (cold PBS containing 2 mM EDTA and 2 mM EGTA). From this point on, all preparations were kept at 4°C. Cells were scraped in 10 ml of wash buffer and subjected to centrifugation at 1,000 g for 5 min to pellet cells. The pellet was resuspended in 10 ml of extraction buffer [20 mM Tris, pH 7.5, 2 mM EDTA, 2 mM EGTA, and protease inhibitor cocktail tablets (EDTA free; Roche Molecular Biochemicals, Indianapolis, IN)] containing 10% sucrose. Cells were homogenized for three 15-s bursts using the top setting of high-speed cutting blades (T-25, Tissumizer Mark; Tekmar-Dohrmann). The homogenate was centrifuged at 750 g for 5 min at 4°C, and the supernatant was then subjected to centrifugation at 163,000 g for 1 h at 4°C. The final pellet was dissolved in a small volume (0.5-1.0 ml) of extraction buffer containing 1% SDS. An aliquot was diluted 1:10 with water for protein determination. Frozen whole rat brain was crushed in a cold mortar and pestle. The ground tissue was resuspended in 10 ml of cold extraction buffer containing 10% sucrose and homogenized and centrifuged as described above for cultured cells.
Immunoblot analysis was performed as previously described (12) with minor modifications. Total protein (200-400 g) was solubilized in sample buffer and subjected to electrophoresis through discontinuous 8% polyacrylamide gels. After overnight transfer to polyvinylidene difluoride filters, blocking, primary antibody, secondary antibody, and chemiluminescence detection were performed as described (12) . Primary antibodies specific for adenylyl cyclase I-IV, V/VI, and VII-IX were obtained from Santa Cruz Biotechnology (Santa Cruz, CA) and used at a dilution of 1:200 for 2 h at room temperature. Secondary antibodies (donkey anti-rabbit Ig-horseradish peroxidase for isoforms I-IV and V/VI; donkey anti-goat IgG-horseradish peroxidase for isoforms VII-IX) were used at a dilution of 1:3,000 for 90 min.
Statistics
An unpaired two-tailed t-test was used to compare forskolin-stimulated adenylyl cyclase activities between control (untreated) and pretreated (either phorbol or Sp-cAMPS) cells. A P value of Ͻ0.05 was considered statistically significant.
RESULTS
Detection of Nine Adenylyl Cyclase Isoforms Using Type-Specific Primers
Results using whole tissue RNA preparations. RT-PCR using total RNA from whole human brain yielded products of expected sizes for each of the nine adenylyl cyclase primer sets (positive controls; Figs. 1-3 ). These RT-PCR products were subjected to both restriction enzyme digests and direct sequencing to ensure that they represented an amplified sequence of the intended adenylyl cyclase isoform. The expected size of RT-PCR products, the specific restriction endonucleases that cleave at specific internal sites, and the resulting sizes of digested DNA fragments are presented in Table 2 . Direct sequencing of RT-PCR products amplified with primers specific for adenylyl cyclases I-III and V-IX confirmed that these products represented eight isoforms of human adenylyl cyclase.
Because the adenylyl cyclase sequence for human type IV has not been identified previously, we conducted a homology search of adenylyl cyclase IV from the rat with previously unnamed human cDNA sequences. A previously unidentified human GenBank sequence (AF088070) was found to have 88% cDNA sequence homology and 96% predicted amino acid homology with adenylyl cyclase IV in the rat (GenBank M80633). Conversely, this human cDNA fragment has 81 and 82% cDNA homology to human adenylyl cyclases II and VII, respectively, the two adenylyl cyclase subfamily members with which it would be predicted to most closely resemble at the cDNA level. These findings strongly suggest that this previously unidentified human GenBank sequence is a partial cDNA sequence of human adenylyl cyclase IV. Primers specific for this human sequence yielded a 287-bp fragment. Restriction enzyme digests and direct sequencing confirmed that this product was a portion of GenBank sequence AF088070 and was therefore identified as a component of the 3Ј-coding region of human adenylyl cyclase IV.
RT-PCR using total RNA from whole human trachea demonstrated a product of expected size for adenylyl cyclases III-VII and IX, whereas relatively weak bands were obtained with primers specific for isoforms I, II, and VIII. However, these resulting RT-PCR products in whole human trachea may have come from RNA from any of a number of different cell types present in the whole trachea; therefore, more definitive RT-PCR evaluations were performed with dissected airway smooth muscle and primary cultures of airway smooth muscle cells (described below). RNA from whole rat brain yielded no band with primer sets specific for human adenylyl cyclases I-IV, VI, VII, and IX, consistent with relatively low sequence homology (82-95%) between these human primers and the respective rat or mouse adenylyl cyclase sequences. In contrast, primers designed to amplify human adenylyl cyclase V have high homology to rat adenylyl cyclase V and yielded an RT-PCR product of expected size (Fig. 2) .
Results using RNA isolated from freshly dissected or primary cultures of human airway smooth muscle. Identical RT-PCR results were obtained for all isoforms of adenylyl cyclase primers for RNA extracted from either freshly dissected or primary cultures of human airway smooth muscle. At least three independent RNA samples from each source were analyzed with each set of adenylyl cyclase primers. For adenylyl cyclases III-VII and IX, PCR products of expected size and correct identity were obtained from both sources of RNA using 1.0 g total RNA/reaction. Adenylyl cyclase I was only detected when the amount of total RNA was increased to 5 g/reaction. In contrast, no appropriate RT-PCR products were obtained using 1-5 g of total RNA from either freshly dissected or primary cultures of human airway smooth muscle for either adenylyl cyclase II or VIII despite parallel reactions with RNA from whole human brain, which yielded RT-PCR products of expected size and identity. Additionally, the same smooth muscle RNA used in this series of studies did yield RT-PCR products using primers designed to amplify adenylyl cyclase III, attesting to the integrity of the RNA sample. Fig. 2 . Representative RT-PCR products using human-specific primers of adenylyl cyclases IV, V, and VI in total RNA from whole rat brain, whole human brain, whole human trachea, freshly dissected human airway smooth muscle, and primary cultures of human airway smooth muscle cells. Total RNA (1 g) was used in each RT-PCR reaction. Lane 1, 100-bp ladder of DNA standards. mRNA encoding adenylyl cyclases IV, V, and VI was detected in total RNA extracted from both human airway smooth muscle and cultured human airway smooth muscle cells using 1 g of total RNA. At least 3 experiments with each RNA source yielded identical results. Fig. 1 . Representative RT-PCR products using human-specific primers of adenylyl cyclase (AC) I, AC II, and AC III in total RNA from whole rat brain (RB), whole human brain (HB), whole human trachea (HT), freshly dissected human airway smooth muscle (HASM), and primary cultures of human airway smooth muscle cells (Cx-HASM). Total RNA (1 g) was used in each RT-PCR except in lanes indicated by * in which 5 g of total RNA were used. Lane 1, 100-bp ladder of DNA standards. mRNA encoding adenylyl cyclase III was detected in total RNA extracted from both human tracheal smooth muscle and cultured airway smooth muscle cells using 1 g of total RNA. mRNA encoding adenylyl cyclase I was detected in both samples only when 5 g of total RNA were used. mRNA encoding adenylyl cyclase II was not detected in either sample despite increasing the input total RNA to 5 g. At least 3 experiments with each RNA source yielded identical results.
Parallel negative control tubes were analyzed in each RT-PCR in which either RT or RNA was left out of the reaction mixture. These negative controls yielded no RT-PCR products, suggesting that no cDNA or genomic DNA contamination was present in the RNA samples and that no cDNA contamination was introduced during assembly of RT-PCRs (Fig. 4) .
Restriction enzyme digests and sequencing of PCR products. RT-PCR products for each adenylyl cyclase isoform were isolated from gels and subjected to both Fig. 3 . Representative RT-PCR products using humanspecific primers of adenylyl cyclases VII, VIII, and IX in total RNA from whole rat brain, whole human brain, whole human trachea, freshly dissected human airway smooth muscle, and primary cultures of human airway smooth muscle cells. Total RNA (1 g) was used in each RT-PCR, except lanes indicated by * in which 5 g of total RNA were used. Lane 1, 100-bp ladder of DNA standards. mRNA encoding adenylyl cyclases VII and IX was detected in total RNA extracted from both human airway smooth muscle and cultured human airway smooth muscle cells using 1 g of total RNA. mRNA encoding adenylyl cyclase VIII was not detected in either sample despite increasing the input total RNA to 5 g. At least 3 experiments with each RNA source yielded identical results. restriction enzyme digests and direct sequencing. RT-PCR products for isoforms I, III-VII, and IX were isolated from reactions using RNA from human cultured airway smooth muscle cells. RT-PCR products for isoforms II and VIII were isolated from reactions using RNA from whole human brain. All nine PCR products were digested into fragments of predicted sizes as shown in Table 2 . Additionally, direct sequencing confirmed homology between the isolated RT-PCR products and their respective human adenylyl cyclase cDNA sequences, with homologies of 99-100%.
Addition of control sense templates of isoforms II and VIII to airway smooth muscle RNA.
To confirm that the lack of RT-PCR products for isoforms II and VIII from airway smooth muscle RNA was not the result of nonspecific interference with amplification of these isoforms, control sense RNA transcripts were generated and in serially decreasing concentrations added to airway smooth muscle RNA. This was to ensure that our airway smooth muscle RNA preparations did not nonspecifically interfere with the ability of isoform II or VIII primers to amplify sense RNA in our reaction mixtures. Additionally, this strategy indicated the sensitivity of the RT-PCRs, since the control sense RNA transcripts were added in known quantities.
As shown in Fig. 5 , 10-1,000 fg of control sense RNA input resulted in RT-PCR amplification of the expected 369-bp fragment despite the presence of 1 g of total RNA from human airway smooth muscle in each tube. In contrast, no products were obtained with 1,000 fg of control sense RNA in the absence of reverse transcriptase, and no products were obtained with control sense RNA of Ͻ10 fg. Control tubes lacking the sense control but containing human airway smooth muscle RNA also yielded no products, confirming the experiments shown in Fig. 1 for adenylyl cyclase II.
Similar results were obtained with a control RNA sense template for adenylyl cyclase VIII. As shown in Fig. 6, 10-1 ,000 fg of control sense RNA input resulted in RT-PCR amplification of the expected 543-bp fragment despite the presence of 1 g of total RNA from human airway smooth muscle in each tube. In contrast, no products were obtained with 1,000 fg of control sense RNA in the absence of reverse transcriptase, and no products were obtained with control sense RNA of Ͻ10 fg. Control tubes lacking the sense control but containing human airway smooth muscle RNA also Fig. 4 . Representative control experiment of RT-PCR products using human-specific primers for adenylyl cyclase V in the presence and absence of reverse transcriptase and the presence and absence of RNA. Total RNA from whole rat brain, whole human brain, whole human trachea, freshly dissected human airway smooth muscle, and primary cultures of human airway smooth muscle cells was used. For all 5 RNA sources used in this study, no RT-PCR products occurred in the absence of reverse transcriptase or in the absence of input RNA, suggesting the absence of cDNA or genomic DNA contamination. At least 3 experiments with each RNA source yielded identical results. Similar control experiments with all 9 pairs of adenylyl cyclase primers yielded no products in the absence of reverse transcriptase or input RNA. yielded no products, confirming the experiments shown in Fig. 3 for adenylyl cyclase VIII.
Adenylyl cyclase II protein has been identified in primary cultures of guinea pig airway smooth muscle (25) , and a recent report described adenylyl cyclase II mRNA in total RNA from primary cultures of human airway smooth muscle cells (2) . In an attempt to further confirm our results for adenylyl cyclase II described above, we performed new RT-PCR experiments using the specific primers that were reported to have amplified adenylyl cyclase II in cultured human airway smooth muscle cells (2) . These RT-PCRs yielded products of expected size (702 bp) only in the control whole human brain. No appropriately sized RT-PCR products were obtained from total RNA from either human airway smooth muscle or primary cultures of human airway smooth muscle cells.
Pretreatment of human cultured airway smooth muscle cells with phorbol ester, an agent activating PKC, which, in turn, is known to activate isoforms II, V, and VII (15, 17, 35) and inhibit isoform VI (18), caused a significant increase in forskolin-stimulated adenylyl cyclase activity. Without pretreatment, forskolin-stimulated activity was 2,435 Ϯ 137 pmol cAMP ⅐ well Ϫ1 ⅐ 10 min Ϫ1 , and after 15 min pretreatment with 1 M phorbol ester, activity was 3,670 Ϯ 169 pmol cAMP ⅐ well Ϫ1 ⅐ 10 min Ϫ1 (n ϭ 6; P ϭ 0.0002; Fig.  7A ). In contrast, pretreatment with an agent (100 M Sp-cAMPS) that increases PKA activity, which, in turn, is known to inhibit the activity of isoforms V and VI (13) , resulted in a significant decrease in forskolinstimulated adenylyl cyclase activity. In control cells, forskolin-stimulated activity was 1,803 Ϯ 122 pmol cAMP ⅐ well Ϫ1 ⅐ 10 min Ϫ1 , whereas pretreatment with Sp-cAMPS lowered forskolin-stimulated activity to 1,250 Ϯ 118 pmol cAMP ⅐ well Ϫ1 ⅐ 10 min Ϫ1 (n ϭ 6; P ϭ 0.008; Fig. 7B ).
Immunodetection of adenylyl cyclase proteins was difficult, as previously reported (30) . Commercially available antibodies for isoforms I-V/VI, and VIII detected protein expression in either airway smooth muscle or the positive control, rat brain. In contrast, the commercially available antibodies for isoforms VII and IX did not detect protein in either of these tissues despite increasing the total protein loaded to 400 g/ lane. Adenylyl cyclase proteins of isoforms I-V/VI and VIII were detected in the positive control, rat brain (Figs. 8 and 9 ). In contrast, only isoforms V/VI were detected in cultured human airway smooth muscle cells (Fig. 9 ).
DISCUSSION
The current study demonstrates that the mRNA encoding multiple isoforms of adenylyl cyclase (isoforms I, III-VII, and IX) is expressed in airway smooth muscle. The studies were performed in both freshly dissected human airway smooth muscle and primary cultures of human airway smooth muscle cells. Both preparations were evaluated, since even meticulously dissected airway smooth muscle is not a pure preparation of only airway smooth muscle, whereas the primary cultures of airway smooth muscle cells are a homogeneous cell population that expresses a smooth muscle cell phenotype. Conversely, we were concerned that expression of adenylyl cyclase mRNA may change when freshly isolated airway smooth muscle cells were established as a primary cell line and thus wanted to compare RNA from cultured airway smooth muscle with RNA isolated from freshly dissected human airway smooth muscle. We obtained identical results using RNA from fresh or cultured airway smooth muscle cells, suggesting that our results truly reflect mRNA expression in airway smooth muscle and that isoformspecific expression of adenylyl cyclases is maintained in primary cultures of airway smooth muscle cells. In an attempt to extend this study to the level of protein expression and function, both adenylyl cyclase functional assays and immunodetection of adenylyl cyclase proteins were performed, suggesting that adenylyl cy- Fig. 7 . Forskolin-stimulated adenylyl cyclase activity in human airway smooth muscle cells pretreated for 15 min with either 1 M phorbol 12-myristate 13-acetate (PMA; A) or 100 M of the Sp-diastereomer of adenosine 3Ј,5Ј-cyclic monophosphothioate (Sp-cAMPS; B). Activity was increased by acute phorbol ester pretreatment (consistent with known effects on isoforms II, V, and VII; see Refs. 15, 17, 35, 37) . Acute activation of PKA inhibited activity consistent with known effects on isoforms V and VI (13). * P Ͻ 0.01 compared with control.
clase V may be among the functionally dominant isoforms of adenylyl cyclase in airway smooth muscle.
In the current study, we used a strategy of increasing cell-type purity in an effort to ensure that the detected adenylyl cyclase mRNA isoforms were actually expressed in smooth muscle cells and did not represent mRNA from other contaminating cell types. RNA from whole human brain served as a positive control to ensure that adenylyl cyclase-specific primers successfully amplified respective isoforms of human adenylyl cyclases. RNA from whole rat brain served as a negative control. We then used three different types of RNA preparations from the airway with increasing levels of purity of airway smooth muscle cells. First, RNA from whole human trachea was evaluated, followed by RNA from carefully dissected human tracheal smooth muscle, and finally RNA from primary cultures of human airway smooth muscle cells. Results were identical using RNA isolated from freshly dissected or primary cultures of human airway smooth muscle, but results differed in RNA isolated from whole human trachea. All isoforms except II and VIII were identified in airway smooth muscle, whereas all isoforms were identified in RNA from whole trachea. Moreover, isoform I was detected using only 1 g of total RNA from whole trachea compared with needing 5 g of total RNA in airway smooth muscle to obtain a product. Thus this suggests that adenylyl cyclases II and VIII identified in RNA of whole trachea are arising from cell types other than airway smooth muscle. Additionally, because isoform I was easier to detect in whole tracheal RNA compared with airway smooth muscle RNA, isoform I mRNA likely comprises a larger proportion of the total RNA in whole trachea as opposed to airway smooth muscle.
However, quantitative comparisons between tissues and between adenylyl cyclase isoforms must be made with extreme caution using the technique of RT-PCR. We did not attempt to determine which of the nine isoforms of mRNA encoding adenylyl cyclases are expressed in greatest abundance in the current study because of quantitative limitations of RT-PCR. The intensity of resulting bands from RT-PCRs cannot be directly related to the amount of starting mRNA in a preparation because of several technical limitations that limit the ability to compare band intensities and surmise predominant isoforms. These limitations include the fact that different primer pairs do not anneal with identical affinities to different mRNA targets during reverse transcription or to different cDNA targets during PCR. Moreover, RT and PCR do not occur with perfect annealing and amplification during each cycle, meaning that small differences between annealing and amplification efficiencies in the early rounds of PCR are logarithmically amplified after the typical 30-40 total cycles of PCR. Traditionally competitive templates of cDNA or, ideally, cRNA have been used during competitive PCR or competitive RT-PCR, respectively, to extend the quantitative capabilities of this technique.
This is the first study in any human tissue to systemically evaluate the expression of all nine known isoforms of adenylyl cyclase by RT-PCR. This is in part because the partial sequence for each of the human adenylyl cyclase isoforms has not been known. Currently, eight of the nine isoforms have a known cDNA sequence (21-23, 27, 31, 33) and GenBank direct submissions (U65473 and U65474). Only identification of human adenylyl cyclase IV was lacking. However, two unidentified human partial cDNA sequences with near-perfect homology to each other (AF088070 and AF086230) have 88% cDNA homology and 96% predicted protein homology to the 3Ј-end of the coding region of rat adenylyl cyclase IV. Although these previously unidentified human partial cDNA sequences might be expected to encode other members of this subfamily of human adenylyl cyclases (i.e., isoforms II or VII), human sequence AF088070 had only 81 and 82% homology to human adenylyl cyclases II (GenBank X74210) and VII (GenBank NM_001114), respectively. This close homology to rat adenylyl cyclase IV and lack of homology to related human adenylyl cyclase isoforms is very strong evidence that AF088070 represents a portion of human adenylyl cyclase IV.
A potential limitation of the evaluation of adenylyl cyclase isoform expression by RT-PCR is that this technique may be so sensitive as to amplify mRNA of low abundance that may encode for a physiologically Fig. 8 . Representative immunoblot of adenylyl cyclases I, II, and III in membranes prepared from human cultured airway smooth muscle (hu ASM) or whole rat brain. Isoforms I, II, and III were detected in rat brain but not in airway smooth muscle. Fig. 9 . Representative immunoblot of adenylyl cyclases IV, V/VI, and VIII in membranes prepared from human cultured airway smooth muscle or whole rat brain. Isoforms IV, V/VI, and VIII were detected in rat brain, but only isoform V/VI was detected in airway smooth muscle. insignificant amount of a particular isoform of adenylyl cyclase protein. Characterization of the expression of protein levels of various adenylyl cyclase isoforms in native cells is difficult because of a limited selection of commercially available antibodies and the difficulty in detecting a protein expressed in native tissues at relatively low levels (0.01-0.001% of membrane protein; see Ref. 28) . In an attempt to gain insights into the likely functionally predominant isoforms of adenylyl cyclase protein in airway smooth muscle, we used two approaches. First, immunoblot detection was attempted for all nine isoforms using commercially available antibodies. Second, the known selective effects of PKA and PKC activation on certain adenylyl cyclase isoforms was exploited to implicate potentially functionally important isoforms. Adenylyl cyclase proteins I-V/VI and VIII were detected by immunoblot analysis in membranes prepared from whole rat brain, but only isoform V/VI was detected in airway smooth muscle. This suggests that isoforms V and/or VI may be one of the predominant adenylyl cyclases expressed and is consistent with our RNA results where mRNA encoding isoforms II and VIII was not detected and increased amounts of input RNA (5 g) were necessary to detect isoform I in cultured airway smooth muscle. The failure to detect adenylyl cyclase proteins III and IV may suggest that despite the expression of mRNA in airway smooth muscle, the relative expression of protein is low. Conversely, it is also possible that the affinity of the antibodies for isoforms III and IV is less than that of the antibody for isoform V/VI or that the antibody specificity for the human isoforms of isoforms III and IV is low, accounting for our negative immunoblots in human airway smooth muscle despite detection in rat brain. We were unable to detect proteins for isoforms VII and IX in airway smooth muscle or rat brain, suggesting that either 1) these proteins are expressed at low levels in both tissues, 2) the primary antibodies are of poor quality or low affinity, or 3) the antibodies have low cross-species reactivity (antibody for VII was designed against mouse, and antibody for IX was designed against human). Therefore, immunoblot analysis does not allow for conclusions to be drawn about the expression of isoforms VII and IX in human cultured airway smooth muscle.
Because isoforms V/VI were easily detected at both the mRNA and protein levels, we next performed functional assays to further support their important functional expression. Pretreatment of human cultured airway smooth muscle cells with phorbol ester, an agent activating PKC, which, in turn, is known to acutely activate isoforms II, V, and VII (15, 17, 35) and inhibit isoform VI (18) , resulted in an increase in forskolinstimulated activity. Because isoform II was not detected at the mRNA or protein level, these functional data would suggest that isoforms V or VII may be the functionally predominant isoforms in cultured human airway smooth muscle. This was further supported in adenylyl cyclase functional assays in which cells were pretreated with Sp-cAMPS to activate PKA (known to acutely inhibit isoforms V and VI; see Ref. 13 ), which resulted in decreased forskolin-stimulated adenylyl cyclase activity. Taken together, these functional studies, along with mRNA and immunoblot analyses, suggest that isoform V may be a functionally dominant isoform of adenylyl cyclase (although an important functional role for isoforms VII or IX cannot be ruled out). Despite these functional insights, it should be noted that a full understanding of the effects of acute activation of PKA or PKC on all isoforms of adenylyl cyclase is lacking.
Most previous studies of adenylyl cyclase isoform expression have relied on Northern blot analysis of RNA extracted from whole organs (10, 28) . Although Northern blot analysis is likely to identify the most abundant adenylyl cyclase mRNAs expressed, these studies are hampered by not knowing from which cell type the mRNA originated. For example, the lung is reported to express isoforms II-VII and IX (10, 28) , but it is unknown in these Northern blot studies which cell types are expressing these mRNAs, since RNA extracted from whole lung contains RNA from pulmonary, vascular, neural, and hematopoietic cells. To understand unique cell type-specific regulation of adenylyl cyclase isoforms, directed evaluation of isoformspecific expression needs to be evaluated in individual cell types.
A limited number of studies have evaluated the expression of adenylyl cyclase mRNA isoforms in smooth muscle, and even fewer studies have evaluated their expression in airway smooth muscle. Northern blot analysis has been used to evaluate adenylyl cyclase mRNA expression in vascular, gut, and uterine smooth muscle. Adenylyl cyclase III but not I or VIII was identified in rat aortic smooth muscle (36) , whereas guinea pig ileal smooth muscle was found to express isoforms I and IV (26) by Northern blotting. Uterine smooth muscle was found to express isoforms II-VI and IX in humans and II-VII and IX in rats by Northern analysis (20) . Using the more sensitive technique of RT-PCR, we recently demonstrated mRNA for isoforms II-IX plus a unique splice variant for isoform IV in rat uterine smooth muscle (6) .
The current study agrees in part with a recent study in cultured human airway smooth muscle cells in which four isoforms of adenylyl cyclase mRNA were identified (2). RT-PCR employing predominantly degenerate primers was used to evaluate adenylyl cyclase mRNA expression. Isoforms VI and IX were identified using nonselective degenerate primers, and isoforms II and VII were identified using isoform-specific primers. In contrast, in the current study, we did not identify mRNA for isoform II in RNA isolated from either cultured or freshly isolated airway smooth muscle despite using the same primers and PCR conditions. Additionally, in the present study, a second pair of isoform II primers did not identify isoform II mRNA from either cultured or freshly isolated airway smooth muscle. Both sets of primers for isoform II yielded RT-PCR products of expected sizes using RNA from whole brain or using a positive control template for isoform II, suggesting that both primer sets were capable of amplifying isoform II using the RT-PCR conditions em-ployed in the present study. It is unclear why our results with isoform II differ from this previous study (2) , but our results in cultured cells concur with our results in freshly isolated airway smooth muscle.
The current study does not agree with a previous study in primary cultures of guinea pig airway smooth muscle cells in which immunoblot analysis identified the expression of adenylyl cyclase II protein (25) . This previous study did not attempt to evaluate the expression of other adenylyl cyclase isoforms but differs from the current study in that type II was not identified in RNA from freshly dissected or primary cultures of human airway smooth muscle cells. This suggests a possible species difference in the expression of adenylyl cyclase isoforms in airway smooth muscle.
In summary, we have identified mRNA encoding for the expression of multiple isoforms of adenylyl cyclase in human airway smooth muscle. Results were identical in RNA isolated from freshly dissected and primary cultures of human airway smooth muscle. Immunoblot and functional assays suggest that isoform V is one of the functionally significant isoforms of adenylyl cyclase in human airway smooth muscle. These results suggest that the synthesis of cAMP in an airway smooth muscle cell is the net result of the activities of multiple isoforms of uniquely regulated adenylyl cyclases.
